Unveiling common transcriptomic features between melanoma brain metastases and neurodegenerative diseases
CBL Lab
NYU Langone Health
Neurodegenerative diseases
Parkinson’s disease
Systematic review
Overview
Overview
Theoretical Framework
Melanoma brain metastasis
Melanoma brain metastasis
Neurodegenerative diseases
Alzheimer’s disease
Systematic review
Individual analysis of selected sudies
GSE118553
GSE125583
GSE1297
GSE132903
GSE15222
GSE29378
GSE37263
GSE48350
GSE5281
GSE84422
Meta-analyses results
Parkinson’s disease
Systematic review
Individual analysis of selected sudies
E-MEXP-1416
GSE7621
GSE8397
GSE20146
GSE28894
GSE20295
Meta-analyses results
Multiple sclerosis
Systematic review
Individual analysis of selected sudies
GSE108000
GSE111972
GSE131281
GSE135511
Meta-analyses results
Melanoma brain-specific metastasis signature
Neurodegenerative signature
Functional profiling
Melanoma brain metastasis tumoral signature
Neurodegenerative signature
Functional profiling
Methods
Methods
Systematic review
Diagram of the systematic reviews conducted for Parkinson’s disease.
Multistep systematic review according to PRISMA statement guidelines (PMID: 19621072). The number of retained or discarded studies are indicated at each phase (n). PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Description of the selected studies:
Back to top